BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8393489)

  • 1. A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines.
    Naylor A; Judd DB; Lloyd JE; Scopes DI; Hayes AG; Birch PJ
    J Med Chem; 1993 Jul; 36(15):2075-83. PubMed ID: 8393489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-[(Alkylamino)methyl]furo[3,2-c]pyridines: a new series of selective kappa-receptor agonists.
    Naylor A; Judd DB; Scopes DI; Hayes AG; Birch PJ
    J Med Chem; 1994 Jul; 37(14):2138-44. PubMed ID: 8035420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New kappa-receptor agonists based upon a 2-[(alkylamino)methyl]piperidine nucleus.
    Scopes DI; Hayes NF; Bays DE; Belton D; Brain J; Brown DS; Judd DB; McElroy AB; Meerholz CA; Naylor A
    J Med Chem; 1992 Feb; 35(3):490-501. PubMed ID: 1310743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
    Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
    Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
    Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
    J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
    Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure/activity studies related to 2-(3,4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]acetamides: a novel series of potent and selective kappa-opioid agonists.
    Barlow JJ; Blackburn TP; Costello GF; James R; Le Count DJ; Main BG; Pearce RJ; Russell K; Shaw JS
    J Med Chem; 1991 Nov; 34(11):3149-58. PubMed ID: 1659636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A series of novel, highly potent and selective agonists for the kappa-opioid receptor.
    Hayes AG; Birch PJ; Hayward NJ; Sheehan MJ; Rogers H; Tyers MB; Judd DB; Scopes DI; Naylor A
    Br J Pharmacol; 1990 Dec; 101(4):944-8. PubMed ID: 1964823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists.
    Costello GF; James R; Shaw JS; Slater AM; Stutchbury NC
    J Med Chem; 1991 Jan; 34(1):181-9. PubMed ID: 1846918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
    Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
    Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
    Hayes A; Kelly A
    Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
    Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
    Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CI-977, a novel and selective agonist for the kappa-opioid receptor.
    Hunter JC; Leighton GE; Meecham KG; Boyle SJ; Horwell DC; Rees DC; Hughes J
    Br J Pharmacol; 1990 Sep; 101(1):183-9. PubMed ID: 2178014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of R-84760, a novel kappa-opioid receptor agonist.
    Fujibayashi K; Sakamoto K; Watanabe M; Iizuka Y
    Eur J Pharmacol; 1994 Aug; 261(1-2):133-40. PubMed ID: 8001635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonists.
    Kumar V; Guo D; Cassel JA; Daubert JD; Dehaven RN; Dehaven-Hudkins DL; Gauntner EK; Gottshall SL; Greiner SL; Koblish M; Little PJ; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1091-5. PubMed ID: 15686919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly selective kappa-opioid analgesics. 3. Synthesis and structure-activity relationships of novel N-[2-(1-pyrrolidinyl)-4- or -5-substituted-cyclohexyl]arylacetamide derivatives.
    Halfpenny PR; Horwell DC; Hughes J; Hunter JC; Rees DC
    J Med Chem; 1990 Jan; 33(1):286-91. PubMed ID: 2153208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antinociceptive activity, and opioid receptor profiles of substituted trans-3-(decahydro- and octahydro-4a-isoquinolinyl)phenols.
    Judd DB; Brown DS; Lloyd JE; McElroy AB; Scopes DI; Birch PJ; Hayes AG; Sheehan MJ
    J Med Chem; 1992 Jan; 35(1):48-56. PubMed ID: 1310115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.